首页> 美国卫生研究院文献>American Journal of Respiratory and Critical Care Medicine >An Official American Thoracic Society/European Respiratory Society Statement: Update on Limb Muscle Dysfunction in Chronic Obstructive Pulmonary Disease
【2h】

An Official American Thoracic Society/European Respiratory Society Statement: Update on Limb Muscle Dysfunction in Chronic Obstructive Pulmonary Disease

机译:美国胸科学会/欧洲呼吸学会的正式声明:慢性阻塞性肺疾病中肢体肌肉功能障碍的最新进展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

>Background: Limb muscle dysfunction is prevalent in chronic obstructive pulmonary disease (COPD) and it has important clinical implications, such as reduced exercise tolerance, quality of life, and even survival. Since the previous American Thoracic Society/European Respiratory Society (ATS/ERS) statement on limb muscle dysfunction, important progress has been made on the characterization of this problem and on our understanding of its pathophysiology and clinical implications.>Purpose: The purpose of this document is to update the 1999 ATS/ERS statement on limb muscle dysfunction in COPD.>Methods: An interdisciplinary committee of experts from the ATS and ERS Pulmonary Rehabilitation and Clinical Problems assemblies determined that the scope of this document should be limited to limb muscles. Committee members conducted focused reviews of the literature on several topics. A librarian also performed a literature search. An ATS methodologist provided advice to the committee, ensuring that the methodological approach was consistent with ATS standards.>Results: We identified important advances in our understanding of the extent and nature of the structural alterations in limb muscles in patients with COPD. Since the last update, landmark studies were published on the mechanisms of development of limb muscle dysfunction in COPD and on the treatment of this condition. We now have a better understanding of the clinical implications of limb muscle dysfunction. Although exercise training is the most potent intervention to address this condition, other therapies, such as neuromuscular electrical stimulation, are emerging. Assessment of limb muscle function can identify patients who are at increased risk of poor clinical outcomes, such as exercise intolerance and premature mortality.>Conclusions: Limb muscle dysfunction is a key systemic consequence of COPD. However, there are still important gaps in our knowledge about the mechanisms of development of this problem. Strategies for early detection and specific treatments for this condition are also needed.
机译:>背景:肢体肌肉功能障碍在慢性阻塞性肺疾病(COPD)中很普遍,并且具有重要的临床意义,例如降低运动耐力,生活质量甚至生存。自上次美国胸科学会/欧洲呼吸学会(ATS / ERS)关于肢体肌肉功能障碍的声明以来,在此问题的表征以及我们对其病理生理学和临床意义的理解上已经取得了重要进展。>目的:本文档旨在更新1999年关于COPD肢体肌肉功能障碍的ATS / ERS声明。>方法: ATS和ERS肺康复和临床问题大会的跨学科专家委员会确定,本文件的范围应限于肢体肌肉。委员会成员对有关几个主题的文献进行了重点审查。图书馆员还进行了文献检索。一名ATS方法专家向委员会提供了建议,以确保该方法论方法符合ATS标准。>结果:我们在了解患者肢体肌肉结构改变的程度和性质方面确定了重要的进展与COPD。自上次更新以来,发表了具有里程碑意义的研究,涉及COPD肢体肌肉功能障碍的发展机制以及这种情况的治疗。现在,我们对肢体肌肉功能障碍的临床意义有了更好的了解。尽管运动训练是解决此问题的最有效干预手段,但其他疗法(如神经肌肉电刺激)正在兴起。评估肢体肌肉功能可以识别出临床结果不良风险增加的患者,例如运动不耐症和过早死亡。>结论:肢体肌肉功能障碍是COPD的关键系统性后果。但是,我们对这个问题的发展机理的认识仍然存在重要差距。还需要针对这种情况的早期发现策略和特定治疗方法。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号